PSMA-targeted based positron emission tomography (PET)/computer tomography (CT) with radiolabeled PSMA ligands, such as [68Ga]Ga-PSMA-11, is frequently used for imaging of prostate cancer in clinical routine [13]. This evidence concerns the gene FOLH1 and prostate carcinoma.